Monday, August 22, 2016

BRIEF-Puma Biotechnology's marketing authorization application for neratinib validated by EMA

* Marketing authorization application for neratinib has been

validated by European Medicines Agency

Source text (http://bit.ly/2bxvgWa)

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)